Foci Pharma Seeks EU Approval of TCM

Foci Pharmaceutical Co. of China is applying for European authorization to sell its Chinese angelica product in Europe. In 2004, the EU told herbal medication companies that, unless they register their products by April 2011, they must withdraw the products from the European marketplace. To date, no China TCM company has succeeded in attaining EU approval for their product(s). But Foci is convinced it has found a pathway to comply with European regulations. More details.... Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});